Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not contr (Q48226441)
Jump to navigation
Jump to search
scientific article published on 6 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not contr |
scientific article published on 6 October 2014 |
Statements
1 reference
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not contr (English)
1 reference
M W Stewart
1 reference
C M Perkins
1 reference
D T Cirkel
1 reference
J Ye
1 reference
C R Perry
1 reference
R R Reinhardt
1 reference
B W Bode
1 reference
6 October 2014
1 reference
16
1 reference
1257-1264
1 reference
12
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference